4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Oxford Biomedica plc (OXB) operates in the Biotechnology industry and is headquartered in Oxford, United Kingdom with about 977 employees. Its market capitalization is roughly £589 million. In the fiscal year ended 2025-12-31, OXB reported £169M in revenue and (£30M) in net income.
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | £169M | £129M | £90M | £140M |
| Gross Profit | £66M | £53M | £40M | £69M |
| Operating Income (EBIT) | (£33M) | (£44M) | (£88M) | (£52M) |
| Net Income | (£30M) | (£43M) | (£158M) | (£39M) |
GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | £326M | £232M | £252M | £460M | — |
| Total Liabilities | £234M | £171M | £174M | £224M | — |
GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OXB viewer.
About TickerBase · Data methodology & sources · Privacy · Terms